The purpose of the study is to evaluate the effects of Cholecalciferol (Vitamin D3) substitution on the posttransplant outcome (glomerular filtration rate as well as serum creatinine levels, number of acute rejection episodes, number of infections and C-reactive protein levels within the first year after transplantation) in vitamin D deficient kidney transplant recipients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The immunologic effects of Vitamin D3 substitution in vitamin D deficient kidney transplant recipients will be evaluated by means of: Glomerular filtration rate
Timeframe: one year after kidney transplantation
Number of acute rejection episodes
Timeframe: one year after kidney transplantation
Number of infections
Timeframe: one year after kidney transplantation
CRP levels
Timeframe: one year after kidney transplantation
Courses of calcium levels
Timeframe: within the first year after kidney transplantation